JP Morgan Private Wealth Advisors’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.35M Buy
+38,304
New +$1.46M ﹤0.01% 876
2023
Q2
Sell
-57,309
Closed -$2.16M 1638
2023
Q1
$2.16M Sell
57,309
-623
-1% -$23.9K ﹤0.01% 851
2022
Q4
$2.46M Sell
57,932
-12,647
-18% -$521K 0.01% 776
2022
Q3
$2.27M Sell
70,579
-3,167
-4% -$111K 0.01% 802
2022
Q2
$2.4M Buy
73,746
+13,758
+23% +$446K 0.01% 785
2022
Q1
$2.17M Buy
59,988
+5,758
+11% +$198K ﹤0.01% 871
2021
Q4
$2.15M Buy
54,230
+655
+1% +$27.3K ﹤0.01% 879
2021
Q3
$2.34M Buy
53,575
+2,421
+5% +$109K 0.01% 838
2021
Q2
$2.09M Buy
51,154
+7,782
+18% +$300K 0.01% 863
2021
Q1
$1.42M Sell
43,372
-2,391
-5% -$89.9K ﹤0.01% 893
2020
Q4
$1.86M Buy
45,763
+4,810
+12% +$180K 0.01% 760
2020
Q3
$1.5M Buy
40,953
+28,480
+228% +$1.03M 0.01% 732
2020
Q2
$423K Sell
12,473
-1,400
-10% -$38.2K ﹤0.01% 1177
2020
Q1
$294K Buy
+13,873
New +$309K ﹤0.01% 1142

Other funds holding GMAB

JP Morgan Private Wealth Advisors's GMAB Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors opened a new position in Genmab (GMAB) in Q3 2023: 38,304 shares worth $1.35M. The stake represents ﹤0.01% of the portfolio and ranks #876 among its holdings. This is a return to the name: JP Morgan Private Wealth Advisors previously reported a position in GMAB as recently as Q1 2023.

JP Morgan Private Wealth Advisors first reported a position in GMAB in Q1 2020 and has held it in 14 quarters since. The position peaked at $2.46M in Q4 2022. 234 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 38,304 shares of Genmab worth $1.35M as of Q3 2023.
  • Genmab was a new JP Morgan Private Wealth Advisors position in Q3 2023.
  • Genmab made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #876 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Genmab in Q1 2020 and has held it in 14 quarters since.
  • JP Morgan Private Wealth Advisors's Genmab position peaked at $2.46M in Q4 2022.
  • 234 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.